Skip to content

Update (December 4, 2012) On The Status Of Vertex Pharmaceuticals’ Orphan Drug Kalydeco (Ivacaftor) In The UK

December 4, 2012

       The Cystic Fibrosis Trust UK issues a December 4, 2012, update : 

–  Final decision, confirmed by the Specialist Commission Group (SCG), on Kalydeco funding is expected to be made by the week beginning December 17, 2012, following Board meetings of all 4 SCGs   

–  This announcement is made after a Health Minister’s statement last week that a decision on Kalydeco funding was delayed until January 2013.

Copyright © 2012-2013, Orphan Druganaut Blog.  All rights reserved.

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: